For apixaban or dabigatran, what is the recommended action regarding the morning dose before a procedure?

• A. Miss morning dose
• B. Take the morning dose as scheduled
• C. Delay the evening dose
• D. Skip both morning and evening doses

Answer: (A)

In perioperative care for direct oral anticoagulants like apixaban and dabigatran, the aim is to minimize bleeding during the procedure by lowering the drug level while not leaving the patient unprotected for too long. These drugs have relatively short half-lives, so skipping the morning dose reduces anticoagulant activity at the time of the procedure without requiring a full break from therapy.

Miss morning dose is the best approach because it lowers the risk of bleeding during the procedure. Taking the morning dose as scheduled would keep the anticoagulant effect high when you’re cutting or suturing, increasing bleeding risk. Delaying the evening dose after a morning procedure doesn’t address the exposure during the actual procedure, since the morning dose would still be present. Skipping both doses would leave the patient without adequate protection against thrombosis for an unnecessary length of time.

After the procedure, anticoagulation is resumed once hemostasis is secured and the patient’s bleeding risk is acceptable.